Zoekresultaten - 31 results

Surveillance of Bloodstream Infections in Belgian Hospitals- Annual report 2023, Data up to and including 2022

times higher as compared to hospital-wide HABSI. As with hospital-wide HABSI, ICU- BSI incidences also show decreasing trends since 2020, but their 2022 incidence also remains higher as compared to 2019 ...

Surveillance of Bloodstream Infections in Belgian Hospitals- Annual report 2023, Data up to and including 2022

multiple times higher as compared to hospital-wide HABSI. As with hospital-wide HABSI, ICU- BSI incidences also show decreasing trends since 2020, but their 2022 incidence also remains higher as compared to ...

Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries

related death. Relative vaccine effectiveness also waned with time, falling to ≤50% after 24 weeks. In the most recent estimate, between February and March 2023, rVE of the second booster ranged between ...

Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)

following the autumn vaccination campaign of 2022, compared to those who did not receive a vaccine during this time. Health Topics:  Vaccin Vaccin Vaccin Service:  Épidémiologie des maladies infectieuses ...

Epidemiology of COVID-19 mortality in Belgium from wave 1 to wave 7 (March 2020 – 11 September 2022)

men, across all age groups. COVID-19 CFR decreased over time. All-cause and excess mortality The all-cause CMR for Belgium was the highest for wave 2 (522 per 100,000 inhabitants). The number of deaths ...

RESISTIRE factsheet: Mental Health Support in Times of Crisis

Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Claudia Aglietti; Marina Cacace; Federica Rossetti; Rana Charafeddine; Agnieszka Kolasinska Source: (2023) Manuscript versions:  DOI:  https://doi.org/10.5281/zenodo ...

Healthy Data, an online citizen consultation about health data reuse – intermediate report

allow for citizens to know in real time what data is being used, who it is being used by, how they are using it and what their intentions are. At this higher level of complexity and involvement, they ...

Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)

this time period. During the second period of wave 2 (25/10-21/11) the prevalence increased further to 92.9%. Among the fully vaccinated having received the last dose (eventually a booster) in the past ...

Surveillance of COVID-19 mortality in Belgium, epidemiology and methodology during 1st and 2nd wave (March 2020- 14 February 2021)

implemented at the start of the epidemic to acquire real-time COVID-19 mortality data on a daily basis. The surveillance combined information on COVID-19 related deaths from three surveillances (the hospital ...

Excess mortality during the first and second waves of the COVID-19 epidemic in Belgium

a 17.5% excess mortality with 18,765 additional deaths, eight times the average excess mortality of the past five years. In the absence of the implementation of restrictive measures (e.g., social ...

QR code

QR code for this page URL